PUBLISHER: TechNavio | PRODUCT CODE: 2056206
PUBLISHER: TechNavio | PRODUCT CODE: 2056206
Global Veterinary Vaccines Market 2026-2030
The global veterinary vaccines market is forecasted to grow by USD 3628.3 mn during 2025-2030, accelerating at a CAGR of 6.3% during the forecast period. The report on the global veterinary vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating incidence of zoonotic pathogens and infectious animal diseases, rising demand for animal protein and intensive commercial agriculture, humanization of companion animals and increasing veterinary expenditures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 6.1% |
| CAGR | 6.3% |
| Incremental Value | $3628.3 mn |
Technavio's global veterinary vaccines market is segmented as below:
By Type
- Live attenuated
- Inactivated
- Recombinant
- DNA
- Toxoid
By Application
- Livestock
- Poultry
- Companion animal
- Equine
- Aquaculture
By Route Of Administration
- Subcutaneous
- Intramuscular
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the accelerated integration of mrna technology and next-generation platforms as one of the prime reasons driving the global veterinary vaccines market growth during the next few years. Also, deployment of ai and digital analytics in antigen selection and mutation prediction and rising demand for veterinary vaccines on multi-disease combination and multi-valent formulations will lead to sizable demand in the market.
The report on the global veterinary vaccines market covers the following areas:
- Global veterinary vaccines market sizing
- Global veterinary vaccines market forecast
- Global veterinary vaccines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global veterinary vaccines market vendors that include Bimeda Holdings Ltd., Biogenesis Bago SA, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Fatro S.p.A., Hester Biosciences Ltd., HIPRA SA, Huvepharma Inc, IDT Biologika GmbH, Indian Immunologicals Ltd., Laboratorios Calier S.A., Meiji Holdings Co. Ltd., Neogen Corp., Phibro Animal Health Corp., Vaxxinova International BV, Vetoquinol SA, Virbac Group, Zoetis Inc.. Also, the global veterinary vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Veterinary Vaccines Market 2020 - 2024
- Historic Market Size - Data Table on Global Veterinary Vaccines Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.4 Route of Administration segment analysis 2020 - 2024
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global veterinary vaccines market
- 6.2 Impact of geopolitical conflicts on global veterinary vaccines market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Live attenuated - Market size and forecast 2025-2030
- 8.4 Inactivated - Market size and forecast 2025-2030
- 8.5 Recombinant - Market size and forecast 2025-2030
- 8.6 DNA - Market size and forecast 2025-2030
- 8.7 Toxoid - Market size and forecast 2025-2030
- 8.8 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Livestock - Market size and forecast 2025-2030
- 9.4 Poultry - Market size and forecast 2025-2030
- 9.5 Companion animal - Market size and forecast 2025-2030
- 9.6 Equine - Market size and forecast 2025-2030
- 9.7 Aquaculture - Market size and forecast 2025-2030
- 9.8 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Market Segmentation by Route of Administration
- 10.1 Market segments
- 10.2 Comparison by Route of Administration
- 10.3 Subcutaneous - Market size and forecast 2025-2030
- 10.4 Intramuscular - Market size and forecast 2025-2030
- 10.5 Others - Market size and forecast 2025-2030
- 10.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Escalating incidence of zoonotic pathogens and infectious animal diseases
- Rising demand for animal protein and intensive commercial agriculture
- Humanization of companion animals and increasing veterinary expenditures
- 13.2 Market challenges
- High cost barrier and low immunization awareness in emerging agricultural economies
- Inadequate infrastructure and cold-chain logistics vulnerabilities
- Stringent, fragmented, and protracted regulatory approval pathways
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Accelerated integration of mRNA technology and next-generation platforms
- Deployment of AI and digital analytics in antigen selection and mutation prediction
- Rising demand for veterinary vaccines on multi-disease combination and multi-valent formulations
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Bimeda Holdings Ltd.
- Bimeda Holdings Ltd. - Overview
- Bimeda Holdings Ltd. - Product / Service
- Bimeda Holdings Ltd. - Key offerings
- SWOT
- 15.5 Biogenesis Bago SA
- Biogenesis Bago SA - Overview
- Biogenesis Bago SA - Product / Service
- Biogenesis Bago SA - Key offerings
- SWOT
- 15.6 Boehringer Ingelheim GmbH
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
- 15.7 Ceva Sante Animale
- Ceva Sante Animale - Overview
- Ceva Sante Animale - Product / Service
- Ceva Sante Animale - Key offerings
- SWOT
- 15.8 Dechra Pharmaceuticals Plc
- Dechra Pharmaceuticals Plc - Overview
- Dechra Pharmaceuticals Plc - Product / Service
- Dechra Pharmaceuticals Plc - Key offerings
- SWOT
- 15.9 Elanco Animal Health Inc.
- Elanco Animal Health Inc. - Overview
- Elanco Animal Health Inc. - Product / Service
- Elanco Animal Health Inc. - Key offerings
- SWOT
- 15.10 Hester Biosciences Ltd.
- Hester Biosciences Ltd. - Overview
- Hester Biosciences Ltd. - Business segments
- Hester Biosciences Ltd. - Key offerings
- Hester Biosciences Ltd. - Segment focus
- SWOT
- 15.11 IDT Biologika GmbH
- IDT Biologika GmbH - Overview
- IDT Biologika GmbH - Product / Service
- IDT Biologika GmbH - Key offerings
- SWOT
- 15.12 Indian Immunologicals Ltd.
- Indian Immunologicals Ltd. - Overview
- Indian Immunologicals Ltd. - Product / Service
- Indian Immunologicals Ltd. - Key offerings
- SWOT
- 15.13 Meiji Holdings Co. Ltd.
- Meiji Holdings Co. Ltd. - Overview
- Meiji Holdings Co. Ltd. - Business segments
- Meiji Holdings Co. Ltd. - Key offerings
- Meiji Holdings Co. Ltd. - Segment focus
- SWOT
- 15.14 Neogen Corp.
- Neogen Corp. - Overview
- Neogen Corp. - Business segments
- Neogen Corp. - Key offerings
- Neogen Corp. - Segment focus
- SWOT
- 15.15 Phibro Animal Health Corp.
- Phibro Animal Health Corp. - Overview
- Phibro Animal Health Corp. - Business segments
- Phibro Animal Health Corp. - Key offerings
- Phibro Animal Health Corp. - Segment focus
- SWOT
- 15.16 Vaxxinova International BV
- Vaxxinova International BV - Overview
- Vaxxinova International BV - Product / Service
- Vaxxinova International BV - Key offerings
- SWOT
- 15.17 Vetoquinol SA
- Vetoquinol SA - Overview
- Vetoquinol SA - Business segments
- Vetoquinol SA - Key offerings
- Vetoquinol SA - Segment focus
- SWOT
- 15.18 Zoetis Inc.
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
